Michael Brian Bell - Jan 15, 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ John Saia, as attorney-in-fact for Michael Brian Bell
Stock symbol: GH
Transactions as of: Jan 15, 2022
Transactions value $: -$96,665
Form type: 4
Date filed: 1/18/2022, 03:38 PM
Next filing: May 26, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GH	COMMON STOCK	Award	$0	+3.31K		$0.00	3.31K	Jan 15, 2022	Direct
transaction	GH	COMMON STOCK	Tax liability	-$96.7K	-1.25K	-37.67%	$77.58	2.06K	Jan 15, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GH	RESTRICTED STOCK UNITS	Options Exercise	$0	-3.31K	-25%	$0.00	9.93K	Jan 15, 2022	COMMON STOCK	3.31K	$0.00	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2	The restricted stock unit vests as to 25% of the shares subject to such award on January 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of January 15, 2022, during the three-year period thereafter.
F3	Not applicable for Restricted Stock Units.